Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
HNO|January 10, 2020
Adenosine production in mesenchymal stromal cells in relation to their developmental statusS S Jeske, M N Theodoraki, E Boelke, et al.
Genes and Immunity|July 29, 2016
Survival of autoreactive T lymphocytes by microRNA-mediated regulation of apoptosis through TRAIL and Fas in type 1 diabetesV M de Jong, A R van der Slik, S Laban, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|February 24, 2017
Response Evaluation in Head and Neck Oncology: Definition and PredictionT K Hoffmann, P J Schuler, S Laban, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|April 20, 2021
Influence of travel burden on tumor classification and survival of head and neck cancer patientsJ M Vahl, A von Witzleben, C Welke, et al.
Genes and Immunity|August 11, 2017
Differential transcriptome of tolerogenic versus inflammatory dendritic cells points to modulated T1D genetic risk and enriched immune regulationT Nikolic, N J C Woittiez, A van der Slik, et al.
Photodiagnosis and Photodynamic Therapy|June 5, 2017
Influence of photodynamic therapy on peripheral immune cell populations and cytokine concentrations in head and neck cancerM N Theodoraki, K Lorenz, R Lotfi, et al.
The Journal of Experimental Medicine|July 6, 2000
Immature dendritic cells acquire CD8(+) cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuliD H Schuurhuis, S Laban, R E Toes, et al.
The Journal of Experimental Medicine|September 6, 2001
Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cellsJ P Medema, D H Schuurhuis, D Rea, et al.
Frontiers in Oncology|October 22, 2025
Health-related quality of life outcomes from KEYNOTE-412: chemoradiotherapy with or without pembrolizumab in participants with head and neck squamous cell carcinomaJ-P Machiels, Y Tao, L Licitra, et al.
Pageof 5